115 related articles for article (PubMed ID: 20818645)
1. Likelihood inference for a two-stage design with treatment selection.
Bebu I; Luta G; Dragalin V
Biom J; 2010 Dec; 52(6):811-22. PubMed ID: 20818645
[TBL] [Abstract][Full Text] [Related]
2. Confidence intervals for confirmatory adaptive two-stage designs with treatment selection.
Bebu I; Dragalin V; Luta G
Biom J; 2013 May; 55(3):294-309. PubMed ID: 23553644
[TBL] [Abstract][Full Text] [Related]
3. Flexible design of two-stage adaptive procedures for phase III clinical trials.
Koyama T
Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
[TBL] [Abstract][Full Text] [Related]
4. Likelihood-based confidence intervals for a log-normal mean.
Wu J; Wong AC; Jiang G
Stat Med; 2003 Jun; 22(11):1849-60. PubMed ID: 12754720
[TBL] [Abstract][Full Text] [Related]
5. Interval estimation of binomial proportion in clinical trials with a two-stage design.
Tsai WY; Chi Y; Chen CM
Stat Med; 2008 Jan; 27(1):15-35. PubMed ID: 17566141
[TBL] [Abstract][Full Text] [Related]
6. Adaptive Dunnett tests for treatment selection.
Koenig F; Brannath W; Bretz F; Posch M
Stat Med; 2008 May; 27(10):1612-25. PubMed ID: 17876763
[TBL] [Abstract][Full Text] [Related]
7. Small-sample confidence sets for the MTD in a phase I clinical trial.
Storer BE
Biometrics; 1993 Dec; 49(4):1117-25. PubMed ID: 8117905
[TBL] [Abstract][Full Text] [Related]
8. A composite design for transition from a preliminary to a full-scale study.
Lachin JM; Younes N
Stat Med; 2007 Nov; 26(27):5014-32. PubMed ID: 17577245
[TBL] [Abstract][Full Text] [Related]
9. On the estimation of the binomial probability in multistage clinical trials.
Jung SH; Kim KM
Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
[TBL] [Abstract][Full Text] [Related]
10. Adaptive designs for confirmatory clinical trials.
Bretz F; Koenig F; Brannath W; Glimm E; Posch M
Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
[TBL] [Abstract][Full Text] [Related]
11. An improved method of evaluating drug effect in a multiple dose clinical trial.
Shen L
Stat Med; 2001 Jul; 20(13):1913-29. PubMed ID: 11427949
[TBL] [Abstract][Full Text] [Related]
12. Comparing the means and variances of a bivariate log-normal distribution.
Bebu I; Mathew T
Stat Med; 2008 Jun; 27(14):2684-96. PubMed ID: 17907261
[TBL] [Abstract][Full Text] [Related]
13. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
Tu D
Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
[TBL] [Abstract][Full Text] [Related]
14. Unconditional efficient one-sided confidence limits for the odds ratio based on conditional likelihood.
Lloyd CJ; Moldovan MV
Stat Med; 2007 Dec; 26(28):5136-46. PubMed ID: 17437251
[TBL] [Abstract][Full Text] [Related]
15. A two-stage phase II trial design utilizing both primary and secondary endpoints.
Lin X; Allred R; Andrews G
Pharm Stat; 2008; 7(2):88-92. PubMed ID: 17252536
[TBL] [Abstract][Full Text] [Related]
16. Sample size tables for exact single-stage phase II designs.
A'Hern RP
Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008
[TBL] [Abstract][Full Text] [Related]
17. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.
Brannath W; Zuber E; Branson M; Bretz F; Gallo P; Posch M; Racine-Poon A
Stat Med; 2009 May; 28(10):1445-63. PubMed ID: 19266565
[TBL] [Abstract][Full Text] [Related]
18. Supplementary analysis of probabilities at the termination of a group sequential phase II trial.
Liu A; Wu C; Yu KF; Gehan E
Stat Med; 2005 Apr; 24(7):1009-27. PubMed ID: 15565737
[TBL] [Abstract][Full Text] [Related]
19. Confidence interval construction for proportion difference in small-sample paired studies.
Tang ML; Tang NS; Chan IS
Stat Med; 2005 Dec; 24(23):3565-79. PubMed ID: 16261646
[TBL] [Abstract][Full Text] [Related]
20. Using the partitioning principle to adaptively design dose-response studies.
Ling X; Hsu J
J Biopharm Stat; 2006; 16(5):733-43. PubMed ID: 17037268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
